Tetra Bio-Pharma Inc.
TBP
주식 순위
#35399
Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical... Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical company focused on discovering and developing cannabinoid-based medications. Their efforts span several therapeutic areas, including inflammation, pain management, ophthalmology, and oncology. The company's pipeline features various drug candidates: PLENITUDE is being developed for cancer-related pain in advanced patients, while REBORN addresses breakthrough cancer pain. Reduvo is designed to combat chemotherapy-induced nausea and vomiting. ARDS-003 targets sepsis and the prevention of acute respiratory distress syndrome, and SERENITY aims to treat cancer cachexia. Furthermore, Tetra Bio-Pharma is advancing PPP003 for painful dry eye and uveitis pain, and HCC011 for hepatocellular carcinoma.
주가
$0.01851783
마지막 동기화: 2023-05-23
시가총액
$3.71M
변동 (1일)
-0.04%
변동 (1년)
1,443.15%
국가
CA
거래 Tetra Bio-Pharma Inc. (TBP)
카테고리
Healthcare
Tetra Bio-Pharma Inc. (TBP)의 주가 이력
최고 종가: $0.00 (2023-10-01 기준)
최저 종가: $0.28 (2011-07-01 기준)
최저 종가: $0.28 (2011-07-01 기준)
Tetra Bio-Pharma Inc.의 주가 이력 (2011 ~ 2026)
연간 주가 성과
| 연도 | 성과 |
|---|---|
| 2023 | -95.84% |
| 2022 | -82.62% |
| 2021 | -21.66% |
| 2020 | -60.26% |
| 2019 | -40.62% |
| 2018 | -5.58% |
| 2017 | 216.26% |
| 2016 | 899.04% |
| 2015 | -56.08% |
| 2014 | 17.07% |
| 2013 | 0.00% |
| 2012 | -69.35% |
| 2011 | 0.00% |
유사 기업 또는 경쟁사의 주가
| 회사 | 주가 | 변동률 1년% | 국가 |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.07 | -4.31% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
